New robotic, image-guided stereotactic radiation system treats cancer patients quickly and effectively with highly accurate tumor targeting
ROYAL OAK, Mich., Oct. 30 /PRNewswire/ -- Beaumont Hospital, Royal Oak (Royal Oak, Michigan, USA) has performed its first treatments using the new Elekta Axesse(TM), the ultimate whole-body cancer treatment system. Elekta Axesse sets new standards for precision and therapeutic efficacy in stereotactic radiation therapy, which involves three-dimensional CT imaging for tumor targeting accuracy.
Since 2006, Beaumont Hospital has been running a successful intracranial radiosurgery program with Leksell Gamma Knife, and the hospital now is expanding its stereotactic treatment offerings to all parts of the anatomy.
"We chose Elekta Axesse because of its versatility," says Alvaro Martinez, M.D., F.A.C.R., corporate chairman, Radiation Oncology, Beaumont Hospitals. "We now can stereotactically treat both intra- and extra-cranial lesions, and the 6D robotically-controlled tabletop gives us the freedom to position the patient at virtually any angle. This enables a much more accurate and precise treatment for these lesions than we could provide in the past."
Integrating advanced technology and software to elevate the patient experience, streamline clinician workflow
The advanced 3D imaging capabilities of Elekta Axesse facilitate rapid, precise targeting of tumors, and the highly-conformal radiation delivery system effectively treats tumors while minimizing damage to patients' healthy tissue.
"Elekta Axesse enables us to attain sub-millimeter accuracy by planning in 3D and imaging patients in 3D prior to treatment, every day," says Dr. Martinez.
Elekta Axesse also integrates non-invasive patient immobilization to
ensure patients properly
|SOURCE Elekta, Inc.|
Copyright©2007 PR Newswire.
All rights reserved